Evexia Lifecare Ltd carries a market capitalization of 3.30B, placing it among publicly traded companies globally. Its enterprise value stands at 1.00B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.30B |
| Enterprise Value | 1.00B |
Evexia Lifecare Ltd currently has 1.88B shares outstanding.
| Shares Outstanding | 1.88B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Evexia Lifecare Ltd trades at a trailing price-to-earnings ratio of 48.34. The price-to-sales ratio is 0.91, and the price-to-book ratio stands at 0.53.
| PE Ratio | 48.34 |
| PS Ratio | 0.91 |
| PB Ratio | 0.53 |
| P/TBV Ratio | 0.23 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Evexia Lifecare Ltd trades at an EV/EBITDA multiple of 53.21 and an EV/FCF ratio of 10,852.53. The EV/Sales ratio of 0.91 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 53.21 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.91 |
| EV / EBITDA | 53.21 |
| EV / EBIT | 53.21 |
| EV / FCF | 10,852.53 |
Evexia Lifecare Ltd maintains a current ratio of 1.39, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.66, indicating moderate leverage, while an interest coverage ratio of 159.34 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.39 |
| Quick Ratio | 0.04 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | 1.53 |
| Interest Coverage | 159.34 |
Evexia Lifecare Ltd posts a return on equity of 1.08 and a return on invested capital of 0.23.
| Return on Equity (ROE) | 1.08 |
| Return on Assets (ROA) | 0.24 |
| Return on Invested Capital (ROIC) | 0.23 |
| Return on Capital Employed (ROCE) | 0.54 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 44.97 |
Over the trailing twelve months, Evexia Lifecare Ltd has paid 5.81M in income taxes, reflecting an effective tax rate of 21.87.
| Income Tax | 5.81M |
| Effective Tax Rate | 21.87 |
Evexia Lifecare Ltd's stock has declined approximately -27.27273% over the past 52 weeks. The 50-day moving average sits at 1.51, while the 200-day moving average is 1.53.
| Beta (5Y) | N/A |
| 52-Week Price Change | -27.27273% |
| 50-Day Moving Average | 1.51 |
| 200-Day Moving Average | 1.53 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Evexia Lifecare Ltd generated 1.10B in revenue and converted that into 20.77M in net income, yielding earnings per share of 0.01. EBITDA reached 18.80M, while operating income came in at 18.80M.
| Revenue | 1.10B |
| Gross Profit | 55.32M |
| Operating Income | 18.80M |
| Pretax Income | 26.59M |
| Net Income | 20.77M |
| EBITDA | 18.80M |
| EBIT | 18.80M |
| Earnings Per Share (EPS) | 0.01 |
Evexia Lifecare Ltd holds 27.71M in cash and equivalents against 28.79M in total debt, resulting in a net debt position of 5.04M. Total book value stands at 1.88B, with working capital of 264.66M providing operational flexibility.
| Cash & Cash Equivalents | 27.71M |
| Total Debt | 28.79M |
| Net Debt | 5.04M |
| Equity (Book Value) | 1.88B |
| Book Value Per Share | 0.99 |
| Working Capital | 264.66M |
Evexia Lifecare Ltd operates with a gross margin of 5.04, reflecting its pricing power and cost economics. The operating margin of 1.71 and net profit margin of 1.89 provide insight into operational efficiency.
| Gross Margin | 5.04 |
| Operating Margin | 1.71 |
| Pretax Margin | 2.42 |
| Profit Margin | 1.89 |
| EBITDA Margin | 1.71 |
Evexia Lifecare Ltd's most recent stock split took place on May 24, 2022 with a 1:2 split ratio.
| Last Split Date | 5/24/2022 |
| Split Ratio | 1:2 |
Evexia Lifecare Ltd posts an Altman Z-Score of 0.31, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.31 |